Small Molecules

05 May 2007 PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
04 May 2007 Biovitrum Initiates Phase II Clinical Trial of Novel Pain Treatment
04 May 2007 Clinical Trial Results Suggest Long-Term Treatment Benefit of Tetrabenazine for Chorea Associated with Huntington's Disease
04 May 2007 Sequella Lead Drug SQ109 Completes Phase 1a Trial
04 May 2007 Array BioPharma Initiates Phase 1 Clinical Trial for Anticancer KSP Inhibitor ARRY-520
04 May 2007 ANX-201 Drug Combination Demonstrates Synergistic Activity Against Human and Bird Flu Viruses
04 May 2007 Incyte Reviews Progress in Multiple Drug Development Programs and Announces First Quarter 2007 Financial Results
04 May 2007 Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
04 May 2007 Cipher Pharmaceuticals Receives Approvable Letter from FDA for CIP-TRAMADOL ER
04 May 2007 IntelGenx Technologies Corp. and Cary Pharmaceuticals Inc. Today Announced Positive Results From a First Pilot Pharmacokinetic (PK) Study On QuitPak (INT003/05)
04 May 2007 First patient enrolled in phase II study of BF-37 in atopic dermatitis
04 May 2007 Xanthus Presents Novel Approach for Autoimmune Disease Reversal with Symadex
04 May 2007 Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose
04 May 2007 Alpharma Presents Positive Pharmacokinetic Study Results of Its Investigational Abuse-Deterrent, Extended-Release Opioid
04 May 2007 CyDex Licenses Captisol(R) to Sunesis Pharmaceuticals for Oncology Drug Candidate
03 May 2007 Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
03 May 2007 Phase III Data on Safinamide in Parkinson's Disease Presented at American Academy of Neurology 59th Annual Meeting
03 May 2007 Spectrum Pharmaceuticals Initiates Phase 3, Registrational Trials With EOquin(R) in Non-Invasive Bladder Cancer
03 May 2007 Last Patient Treated in First Pivotal TH9507 Study
03 May 2007 BioMarin Initiates Phase 2a Clinical Study of 6R-BH4 in Sickle Cell Disease
03 May 2007 FDA Approves Oscient Pharmaceuticals' FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia
03 May 2007 Sunesis Pharmaceuticals Announces Preclinical Milestone Payment in BACE Collaboration with Merck
03 May 2007 Next Pharmaceuticals Reveals Nexrutine(R) Prevents Prostate Cancer Progression in Pre-clinical Animal Model
03 May 2007 FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer
03 May 2007 Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at 20th International Conference on Antiviral Research Meeting

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up